JW Pharmaceutical Corporation (001065.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.5x

Market Cap

KRW 546.82B

MomentumView details →

1D Return

+0.00%

YTD Return

−22.96%

RSI (14)

55.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.5x

Market Cap

KRW 546.82B

RSI (14)

55.3

MomentumView details →

1D Return

+0.00%

YTD Return

−22.96%

ProfitabilityView details →

Gross Margin

47.32%

Net Margin

12.35%

EBITDA Margin

15.33%

ROE (TTM)

24.71%

ROA (TTM)

15.35%

Asset Turnover

1.28x

GrowthView details →

Revenue YoY

+10.44%

EPS YoY

+98.16%

FCF YoY

+347.35%

Revenue CAGR 3Y

+4.22%

EPS CAGR 3Y

+26.00%

EBITDA YoY

+7.45%

EarningsView details →

EPS (Actual)

KRW 1,137.70

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

−1.29%

Capital & dividendView details →

Debt/Equity

0.18x

Current Ratio

1.56x

Quick Ratio

1.06x

Div Yield

2.98%

Div Rate

KRW 675.00

Div Growth 1Y

+42.11%

Financials snapshotView financials →

Revenue (TTM)

820.36B

Net Income (TTM)

101.28B

Op. CF (TTM)

134.48B

Latest newsMore news →

No recent news for 001065.KS.

Similar companies

Shinpoong Pharmaceutical Co., Ltd.019170.KS Dong-A Socio Holdings Co., Ltd.000640.KS JW Pharmaceutical Corporation001060.KS Ildong Pharmaceutical Co., Ltd.249420.KS Bukwang Pharmaceutical Co., Ltd.003000.KS Boryung Corporation003850.KS Find similar companies →

Latest newsMore news →

No recent news for 001065.KS.